INNOVITAL SYSTEMS INC — Department of Defense SBIR Phase II: A16-052

INNOVITAL SYSTEMS INC — SBIR Phase II award from Department of Defense.

Phase II SBIR prototype / development signal

  • Phase II is where Department of Defense funds deeper R&D after feasibility. Incumbents with Phase II history are serious competitors on adjacent topics.
  • Use this award as past-performance context and to map customer organizations for STRATFI/TACFI-style transition planning.
  • Obligated amount $1,099,907 is consistent with substantial Phase II-scale effort; compare to related awards from the same agency.
  • Topic code A16-052 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.

Informational capture context from public federal data — not legal or bid advice.

Amount
$1,099,907
Agency
Department of Defense · Army
Program / Phase
SBIR · Phase II
Topic
A16-052
Solicitation
16.1
NAICS
—
Place of performance
MD
Period
2020-03-12 → 2023-01-23

Description

Current solutions for definitive airway management during pre-hospital combat casualty care are limited, and surgical airways (cricothyrotomies) are frequently unsuccessful. The preferred approach, endotracheal intubation, is often not possible due to inadequate user skill/experience or limitations of the environment/clinical scenario. In multi-domain and prolonged field care environments, trained caregivers may quickly become overburdened, requiring less/untrained providers to assist. Accordingly, tools that decrease the skill and experience required to correctly perform critical patient care procedures will be valuable. Building on extensive experience with device development for combat medicine, InnoVital is developing a semi-autonomous system that enables blind endotracheal intubation – improving the success and ease of definitive airway management in military and civilian pre-hospital settings. The low-cost “SureTube” has similarities to common airway tools, increasing first-attempt success, usability, and provider confidence. A recent user study showed a 91% success rate. In the proposed effort, the “SureTube” system design will be finalized, transitioned to a product, and tested against current approaches (e.g., direct and video laryngoscopy). In addition to InnoVital Systems’ experience with developing procedural aids for combat/pre-hospital care, existing relationships with relevant industry partners puts InnoVital in a strong position for launching the “SureTube” as early as 2023.